Doctor Anywhere, a startup that takes an “omnichannel” approach to healthcare, announced today it has raised $88 million SGD (about $65.7 million USD) in Series C funding. The round was led by Asia Partners, with participation from Novo Holdings, Philips and OSK-SBI Partners. It also included returning investors EDBI, Square Peg, IHH Healthcare, Kamet Capital and Pavilion Capital.
As part of the round, Asia Partners co-founder Oliver Rippel and Novo Holdings Equity Asia senior partner Dr. Amit Kakar will join Doctor Anywhere’s board of directors. The company’s Series C, which it claims is one of the largest private rounds raised by a Southeast Asian health tech company, brings its total funding to more than $140 million SGD.
Doctor Anywhere’s omnichannel approach means that in addition to online consultations, it runs in-person clinics, provides home visits, medication deliveries and operates an in-app marketplace for health and wellness products.
Founded in 2017 by Lim Wai Mun, Doctor Anywhere claims it now serves more than 1.5 million users. It is available in Singapore, Malaysia, Thailand, Vietnam and the Philippines, and recently established tech hubs in Bangalore and Ho Chi Minh City.
Lim told TechCrunch in an email that when he started working on Doctor Anywhere, there were already successful telemedicine platforms in the United States, the United Kingdom and China, but the model was still nascent in Southeast Asia. A former investor, Lim began Doctor Anywhere as a side project after meeting older adults who could not leave their homes for medical visits.
Doctor Anywhere launched as an online-only telehealth platform, but “we quickly realized that physical presence is very important in order to build trust with users,” Lim said. As a result, the company started its home care services and physical clinics.
According to Doctor Anywhere’s estimates, the COVID-19 pandemic fast-tracked the adoption of telehealth services in Southeast Asia by at least five years. The company saw more demand for online medical consultations, medication deliveries and marketplace purchases.
“In the past year, we have more than doubled the size of our network, from around 1,000 providers at the start of 2020 to currently close to 2,500 medical professionals across Southeast Asia,” Lim said.
In response to the pandemic, Doctor Anywhere launched an online COVID-19 Medical Advisory Clinic last year to provide on-demand consultations for people with suspected symptoms. It also created an online mental wellness module with psychologists. Lim said the company has seen an increase in demand for mental-health-related services, like insomnia and anxiety.
Other telehealth startups in the region include WhiteCoat, Speedoc and Doctor World. Lim said Doctor Anywhere wants to differentiate by quickly launching new products in response to user inquiries, and “cultivating a balance between technology and human touch.”
The funding will be used to deepen Doctor Anywhere’s presence in its current markets and expand into new ones. It also plans to scale its tech infrastructure and big data capabilities for a better online-to-offline user experience and will introduce new medical specialty modules, shorten medication delivery times and develop personalized healthcare plans.